Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Psilocybin Therapy for Depression in Bipolar II Disorder (BAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05065294
Recruitment Status : Not yet recruiting
First Posted : October 4, 2021
Last Update Posted : October 4, 2021
Information provided by (Responsible Party):
Joshua Woolley, MD/PhD, University of California, San Francisco

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : September 2023